Últimas noticias sobre Enveric Biosciences (NASDAQ:ENVB) Bolsa

Enveric Biosciences

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAMI

ACEL

AXON

CDNA

CLIK

ENVB

FLYW

HCTI

ICCT

LBTYK

LMND

NAMS

PITA

PRCH

SMCI

ZoomInfo sorprende con resultados mejores de lo esperado y sus acciones suben un 19,6%. Descubre qué otras acciones se están moviendo hoy.

Acciones de ZoomInfo se disparan un 20%; 20 acciones que se están moviendo en el premercado de EE.UU.

Enveric Biosciences Inc

Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>)&nbsp;plans to drive footfall at its grand Orlando theme park with new live events and discounts as it grapples with fierce competition upon pandemic recovery.
The company announced&nbsp;50% percent discounts for children aged 3 to 9 to boost footfall, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-04-09/disney-offers-discounts-shows-as-new-universal-theme-park-looms?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Hotel guests can enjoy free tickets to one of Disney&#8217;s two water parks in Orlando on the first day of their stay.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/02/43887175/disney-appoints-former-paramount-exec-daria-cercek-to-lead-live-action-films-reshaping-studio-leadership" rel="noreferrer noopener">Disney Appoints Former Paramount Exec Daria Cercek to Lead Live-Action Films, Reshaping Studio Leadership</a>
Guests who book rooms for four days or more in certain ticket packages can also enjoy complimentary meals. Disney also&nbsp;cut&nbsp;by half the deposit Florida residents need to put down to purchase an annual pass.
It is worth noting that Comcast Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) NBC Universal Destinations &amp; Experiences will inaugurate Epic Universe theme park on May 22, leading to more competition in the theme park space.
Also, in 2024, Disney announced a decade-long,&nbsp;$60 billion investment&nbsp;in its resorts division.
JPMorgan Chase projected a 1% drop in attendance at Disney&#8217;s Orlando parks this fiscal year, citing Epic Universe&#8217;s impact. During the company conference call, Disney CFO&nbsp;Hugh Johnston reiterated Disney&#8217;s operating income growth guidance of 6%- 8% in 2025 for the resorts division.
BofA Securities&#8217; Jessica Reif Ehrlich&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44539949/disney-analyst-sees-profit-growth-ahead-with-streaming-gains-park-recovery-big-film-releases" rel="noreferrer noopener">cited strong Parks&#8217; rebound</a> and film slate as Disney&#8217;s near-term catalysts. For the fiscal second quarter, Reif Ehrlich maintained revenue of $23.4 billion and $1.25 for EPS. Additionally, she maintained fiscal 2025 revenue of $95.6 billion and EPS of $5.45.
Last December, Rosenblatt&#8217;s Barton Crockett noted that Disney remains focused on its <a target="_blank" href="https://www.benzinga.com/general/entertainment/24/12/42515164/disney-analyst-highlights-streaming-theme-park-portfolio-durability" rel="noreferrer noopener">theme park segment</a> and cruise lines, which will continue to attract guests in the future.
Disney reported <a target="_blank" href="https://www.benzinga.com/25/02/43494650/disney-q1-earnings-powered-by-moana-2-and-mufasa-theme-parks-loses-streaming-subscribers" rel="noreferrer noopener">fiscal first-quarter&nbsp;2025</a> revenue growth of 5% to $24.70 billion, beating the&nbsp;analyst consensus of $24.62 billion. Adjusted EPS of $1.76 beat the&nbsp;analyst consensus of $1.45. For fiscal 2025, Disney reiterated&nbsp;high-single-digit&nbsp;growth in adjusted earnings per share (EPS) compared to 2024 versus a&nbsp;consensus of $5.41.
Price Action: DIS stock is up 10.40% to $90.19 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44673238/apple-faces-eps-hit-from-tariffs-while-doubleverify-and-viant-stay-shielded-with-virtual-revenue-models-analyst" target="_blank" rel="noreferrer noopener">Analyst Forecasts Tariffs Impact On Apple&#8217;s Profit And Highlights 2 Software Stocks That Are Safeguards</a></li>
</ul>
Image via Shutterstock

Media

CMCSA

Disney Cuts Prices And Adds Perks To Lure Families Back To Orlando Parks

WIIM

AMRC

GNRC

KRNT

LYTS

NDSN

NVEE

PPSI

ROAD

STRL

TGLS

Shares of machinery, electrical equipment and engineering companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) on Wednesday announced the new Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google Cloud C4D and H4D virtual machines (VMs), which fifth-generation AMD <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44710585/5th-gen-amd-epyc-processors-deliver-leadership-performance-for-google-cloud-c4d-and-h4d-virtual-ma" rel="noreferrer noopener">EPYC processors power</a>.
The latest additions to Google Cloud&#8217;s general-purpose and HPC-optimized VMs deliver leadership performance, scalability, and efficiency, from data analytics and web serving to high-performance computing (HPC) and AI.
Based on Google Cloud&#8217;s testing, leveraging the advancements of the AMD &#8220;Zen 5&#8221; architecture allowed C4D to deliver up to 80% higher throughput/vCPU compared to previous generations.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/04/44639271/nvidias-custom-gpu-enhances-nintendo-switch-2-with-ai-features-real-time-ray-tracing-4k-support" rel="noreferrer noopener">Nvidia&#8217;s Custom GPU Enhances Nintendo Switch 2 With AI Features, Real-Time Ray Tracing, 4K Support</a>
AMD SVP Dan McNamara noted that its partnership with Google Cloud enabled it to rapidly adopt the latest AMD EPYC processors and deliver consistent high-performance and cost-efficient instances for its most demanding customers.
Google Cloud VP Mark Lohmeyer noted that C4D and H4D instances powered by AMD EPYC processors can help businesses benefit from advanced performance and efficiency tailored to their cloud-native and enterprise applications.
AMD stock plunged 52% in the last 12 months as it battled with Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43788975/amd-closing-competitive-gpu-gap-with-nvidia-gains-market-share-from-intel-in-client-and-server-markets-analyst" rel="noreferrer noopener">for market share</a>.
Wedbush analyst Daniel Ives cited AMD <a target="_blank" href="https://www.benzinga.com/25/04/44698325/trump-tariff-strategy-self-inflicted-market-debacle-says-wedbush-analyst" rel="noreferrer noopener">as among the</a> vulnerable tech companies, including Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Nvidia, after China&#8217;s finance ministry announced a 34%&nbsp;tariff on all goods imported&nbsp;from the U.S., effective April 10, in response to the U.S. administration&#8217;s 54% duties imposed by the Trump-led administration.
Jefferies analysts<a target="_blank" href="https://www.benzinga.com/25/04/44662708/top-analyst-ming-chi-kuo-warns-semiconductor-stocks-face-near-term-risks-under-trump-tariff-policy-even-apples-500-billion-us-investment-didnt-buy-it-leniency" rel="noreferrer noopener"> expect the&nbsp;tariffs</a> to continue to put downward pressure on semiconductor stocks, including AMD.
DA Davidson&#8217;s Gil Luria&nbsp;<a target="_blank" href="https://www.benzinga.com/25/04/44641631/trumps-reciprocal-tariffs-threaten-to-derail-big-techs-billion-dollar-ai-infrastructure-plans-analysts-warn-stargate-was-already-unlikely-to-get-to-that-scale" rel="noreferrer noopener">highlighted that companies like</a>&nbsp;Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and&nbsp;Amazon.com, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) have already begun to scale back their data center investments due to financial uncertainty.
President Trump&#8217;s sweeping new trade tariffs sparked a dramatic sell-off last Thursday. Wall Street witnessed a&nbsp;staggering $2 trillion wiped&nbsp;from market value, with the 10 largest U.S. companies alone accounting for $1 trillion of those losses.
Price Action: AMD stock is up 20.10% at $93.96 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44665533/taiwan-semiconductor-stock-tumbles-as-tariff-fears-spark-global-tech-selloff" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Stock Tumbles As Tariff Fears Spark Global Tech Selloff</a></li>
</ul>
Photo via Shutterstock

Tech

AAPL

AMZN

GOOG

GOOGL

MSFT

NVDA

AMD Powers Google Cloud's New AI Servers Promising 80% Boost In Speed

Macro Economic Events

Economics

Trump Says Deal Could Be Made With China

Rosenblatt Securities analyst Chris Brendler maintained TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) with a Buy and lowered the <a href="https://www.benzinga.com/quote/WULF/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from&nbsp;$10&nbsp;to&nbsp;$4 on Wednesday</a>.
TeraWulf fits perfectly into Brendler&#8217;s Bitcoin mining investment thesis with low power costs, an efficient fleet and a strong balance sheet. Even better, it is one of only three miners to actually sign an HPC deal. Yet the stock has underperformed peers in the recent sell-off due to concerns about its ability to execute and sector-wide worries about the size of the AI opportunity.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/25/04/44672428/analyst-warns-tariffs-could-push-us-bitcoin-mining-build-costs-20-higher" rel="noreferrer noopener">Analyst Warns Tariffs Could Push US Bitcoin Mining Build Costs 20% Higher</a>
Brendler is bullish on both and expects TeraWulf stock to revalue as it powers up Phase 1 later this year and signs additional deals to scale the business.
At the same time, however, Bitcoin mining profitability has dropped dramatically, and current market conditions make it tough to be optimistic about new HPC capital commitments.
Fortunately, the analyst noted that the stock is discounting a lot down here, and TeraWulf should have to execute for it to revalue.
Of all the mining startups that launched in the 2021 bull market, TeraWulf arguably had the most power expertise.
Founded by CEO Paul Prager, TeraWulf&#8217;s executive team has had decades of success in developing, acquiring, and managing power generation facilities at Beowulf Energy, where Prager is still CEO. Over its 30-plus year history, Beowulf has become known for expertise in managing large-scale energy assets and integrating cutting-edge technologies into traditional energy systems. With this deep power experience, TeraWulf&#8217;s power-first approach has proven to be a critical differentiator, first in Bitcoin mining and now in HPC.
In Brendler&#8217;s recent sector initiation report, he favored miners pivoting to HPC due to its superior growth and profitability characteristics. The market supported this view, as HPC-related stocks dramatically outperformed following the June 2024 announcement of the Core Scientific, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>)/CoreWeave, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) deal.
Since rallying to start 2025, the analyst had noted significant pressure on miner-turned-HPC stocks as the market has become increasingly skeptical of the AI opportunity.
In addition to sector-level concerns, Brendler also heard doubts about TeraWulf&#8217;s ability to execute and the strength of its partner, Core42. As a result, after becoming the second public miner to sign a long-term deal with a hyperscaler last year, the best-performing stock in the sector has underperformed so far in 2025.
Brendler noted this sell-off is overdone. He said TeraWulf&#8217;s HPC pivot will prove successful for several reasons.
First, the analyst is highly confident in TeraWulf&#8217;s ability to execute the first phase due to its power expertise and the project&#8217;s manageable size (72 MW). Second, he noted Core42 is an ideal partner. Although not as accomplished or well-known as CoreWeave, Core42 is the digital infrastructure subsidiary of G42, the well-funded (and state-sponsored) leader in AI development in the UAE.
Third, although Core42&#8217;s 135 MW option expired at the end of the first quarter of 2025, recent meetings with management suggested a high degree of confidence in not only 2025 but also TeraWulf&#8217;s annual 150 MW/year target through 2027.
Brendler expected TeraWulf&#8217;s HPC business to exceed market expectations and help the stock rebound.
Although TeraWulf has formally deemphasized the mining business, it still provides 100% of revenue and profitability today. TeraWulf ended 2024 with 9.7 EH/s of mining capacity, which should grow to 13.1 EH/s thanks to 15,000 Bitmain S21 Pros expected to be installed in the first quarter of 2025.
With an impressive 15 J/TH efficiency, TeraWulf&#8217;s fleet should be among industry leaders at just 18.1 J/TH by the first quarter of 2025. This is excellent timing since TeraWulf&#8217;s power costs no longer benefit from the sub-$0.03 per kWh at Nautilus since TeraWulf sold its 50% joint venture interest in October 2024. At this point, management does not expect to expand its mining operations and, as such, no longer provides monthly mining updates.
The shift to HPC can&#8217;t come soon enough, as Bitcoin mining economics have been crushed recently, with the network hash rate spiking to new highs. With Bitcoin falling below $80,000, the hash price has fallen below $40/PH/day for the first time.
In Brendler&#8217;s sector update yesterday, his mining estimates fell sharply across his coverage since his new network forecast includes a ~20% drop in miner profitability.
As a result, his TeraWulf estimates are materially below consensus, with 2025 and 2026 revenue of $195 million and $340 million and adjusted EBITDA of $17 million and $133 million.
Fortunately, much of this outlook is already reflected in the stock price, and Brendler noted significant catalysts ahead.
Given the skepticism around its HPC initiatives, TeraWulf would need to execute Phase 1 to help the stock revalue.
Improving Bitcoin mining profitability would also help, and the analyst noted there is a strong possibility that his new network forecast proves conservative.
Although the current macro environment makes optimism difficult, TeraWulf&#8217;s significant cash position should help it weather the storm.
WULF Price Action: TeraWulf stock is up 11.15% at $2.51 at publication on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44715211/affirm-and-shopify-expand-buy-now-pay-later-to-canada-and-uk-in-global-growth-push" target="_blank" rel="noreferrer noopener">Affirm And Shopify Expand &#8216;Buy Now, Pay Later&#8217; To Canada And UK In Global Growth Push</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Price Target

Reiteration

Analyst Ratings

Core Scientific, Inc. - Class A Common Stock

CORZ

CRWV

WULF

TeraWulf Price Forecast Cut As Analyst Cites Tough Bitcoin Economics, Doubts Over AI Growth Plans

Portfolio managers at global asset manager VanEck say the Trump administration's sweeping new tariff regime is exerting widespread pressure across asset classes, with tangible impacts already visible in digital assets, commodities, emerging markets and fixed income.
What Happened: In an assessment <a href="https://www.vaneck.com/us/en/blogs/investment-outlook/our-portfolio-managers-weigh-impact-of-trumps-tariffs/">released</a> on Tuesday, VanEck professionals flagged recession risk, demand shocks and currency instability as key drivers of short-term market volatility, warning that continued escalation could severely damage investor sentiment and global capital flows.
"These tariffs are much higher and worse than expected," said Roland Morris, VanEck's portfolio manager for commodities. "The outlook for global growth has collapsed."
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), for example, dipped from aggressively following the announcement, though VanEck noted that the digital asset continues to outperform traditional indexes like the Nasdaq. 
Still, the broader message from VanEck is that tariffs have revived trade war uncertainty and weakened the dollar, conditions that have historically influenced asset behavior in multiple sectors.
"The Trump administration's April 2 tariff package has reignited global trade tensions and increased the risk of monetary fragmentation," wrote Matthew Sigel, Head of Digital Assets Research. 
He added that interest in Bitcoin as a neutral settlement tool is no longer theoretical—citing examples of energy transactions being settled in crypto in China, Russia, and Bolivia.
In commodities, the UBS Constant Maturity Commodity Index dropped 6% in two days post-tariff, with copper alone falling 14%.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44697841/raoul-pal-says-crypto-market-nowhere-near-covid-19-peak-fear">Raoul Pal Says Crypto Market Nowhere Near COVID-19 &#8216;Peak Fear&#8217;</a>
"Commodity indexes were near all-time highs on April 2 before collapsing," said Morris. 
He believes the longer-term outlook for gold remains bullish, while a weaker dollar may eventually support a commodity rebound.
Natural resource sectors are also under strain. 
While VanEck's Shawn Reynolds believes that "a large portion of the downside has been priced," he acknowledges that tariff uncertainty is weighing heavily on global recession fears, especially as U.S.–China relations show no sign of improving.
Emerging market bonds and equities are similarly fragile. 
Credit spreads are widening, and while EM currencies initially held firm, they have recently started to falter alongside U.S. equities. 
"Spreads should widen on dollar-denominated bonds," said Eric Fine, Head of Active EM Debt, adding that liquidity risks in corporate debt are increasing.
Fran Rodilosso, Head of Fixed Income ETF Portfolio Management, highlighted that the newly introduced tariffs equate to lower growth expectations and higher risks of a U.S. recession. 
He pointed out that spreads are widening across all risk-related debt categories—from investment-grade bonds to CLOs and high-yield loans.
Even municipal bonds, often perceived as insulated from global trade policy, are facing challenges. 
Tariffs are expected to drive up the cost of infrastructure and healthcare projects, making replacements and expansions fiscally harder to justify. 
"Some projects will be shelved; others will see cost overruns and strained financials," said Senior Municipal Analyst Tamara Lowin.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44698033/millionaire-crypto-trader-reacts-to-bitcoin-mega-crash-you-have-only-one-job-here-survive">Millionaire Crypto Trader Reacts To Bitcoin Mega-Crash: &#8216;You Have Only One Job Here: Survive&#8217;</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

$BTC

Trump Tariffs Are Pressuring Bitcoin, Bonds, Commodities, VanEck Warns

As cannabis legalization debates continue to escalate at both the federal and state levels, a comprehensive new report by <a href="https://themarijuanaherald.com/2025/04/where-all-100-u-s-senators-stand-on-cannabis-law-reform/">The Marijuana Herald</a> maps out where all 100 U.S. Senators stand on major reform issues, including recreational legalization, medical use, decriminalization, banking access and rescheduling. The report offers the most detailed snapshot of the upper chamber's political alignment on marijuana.
<h3 class="wp-block-heading">Partisan Divide: Familiar Lines, New Fractures</h3>
A clear party-line divide remains visible: nearly every Democrat supports all five cannabis reform measures, while most Republicans continue to oppose them, particularly recreational legalization and rescheduling from Schedule I.
Yet there are exceptions. Republican senators like Rand Paul (KY) and Cynthia Lummis (WY) show nuanced or even supportive positions on banking and rescheduling. Paul supports a "state-by-state" approach and has "pushed for marijuana rescheduling and expanded access for veterans," while Lummis voted for the SAFER Banking Act despite opposing legalization.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/04/44720279/is-legal-weed-in-trouble-analyst-says-taxes-oversupply-and-hemp-threat-drove-a-21b-cut-in-sales-estimates">Is Legal Weed In Trouble? Taxes, Oversupply And Hemp Threat Drove A $21-Billion Cut In Sales Estimates</a>
Meanwhile, Democrats like Raphael Warnock (GA) have taken more cautious stances on parts of reform. While supporting decriminalization and rescheduling, Warnock voted against the SAFER Banking Act in committee, citing equity concerns but left the door open for support on the floor.
<h3 class="wp-block-heading">Banking Reform Gains Bipartisan Traction</h3>
The <a href="https://www.benzinga.com/topic/safer-banking-act">SAFER Banking Act</a>—which would allow cannabis businesses access to financial services—emerged as the most bipartisan issue. Roughly 60 senators currently support it, including several Republicans who otherwise oppose legalization, such as Steve Daines (MT), Todd Young (IN) and John Curtis (UT).
Some, like Sen. Rand Paul, framed the issue as one of basic economic fairness: legal cannabis businesses "shouldn't be locked out of banking services just because of federal red tape."
Still, a faction of GOP holdouts remains opposed, including former Banking Committee chair Sen. Mike Crapo (ID), who has blocked previous versions from advancing.
<h3 class="wp-block-heading">Rescheduling Remains Contested</h3>
Though the Biden administration has moved toward rescheduling marijuana to Schedule III, not all senators are on board. While every Democrat supports the change, many Republicans remain firmly against it, including Sen. John Cornyn (TX) and Sen. Tom Cotton (AR), who labeled the push "a dangerous path."
A few Republicans, including Kevin Cramer (ND) and Steve Daines, expressed conditional support, stating openness to changes "based on research."
<h3 class="wp-block-heading">Support For Legalization Still A Minority Position In The GOP</h3>
Of the 49 Republicans in the Senate, only a handful—notably Sen. Rand Paul—express support for full recreational legalization. Even those who back state autonomy, such as Lisa Murkowski (AK) and Susan Collins (ME), are reluctant to endorse nationwide legalization.
Meanwhile, Democratic support is nearly universal, with key figures like Sen. Chuck Schumer actively pushing legislation like the Cannabis Administration and Opportunity Act. Schumer has tied support for SAFER Banking to equity reforms and "urged President Biden to deschedule marijuana."
<h3 class="wp-block-heading">Incoming Senators And Shifting Dynamics</h3>
Newly elected senators bring fresh dynamics. Rep. Ruben Gallego (D-AZ), now a senator, maintains a staunchly pro-cannabis stance, having voted for the MORE Act and advocating for full descheduling. Similarly, Sen. Adam Schiff (D-CA) carries over a pro-reform record from the House.
In contrast, Sen. Bernie Moreno (R-OH)—who defeated cannabis supporter Sherrod Brown—has taken a hardline stance, calling marijuana "a gateway drug" and linking it to "schizophrenia."
<h3 class="wp-block-heading">State-Level Contradictions</h3>
In multiple states where cannabis has been legalized, senators continue to oppose federal reform. This includes both senators from Florida (Rick Scott and Ashley Moody) and South Dakota (John Thune and Mike Rounds), despite strong voter support for legalization at the state level.
Conversely, senators from traditionally conservative states like Montana, Alaska and Utah have shown more willingness to respect voter mandates, particularly on banking and medical access.
<h3 class="wp-block-heading">Reform Outlook: A Divided Senate With Flickers Of Momentum</h3>
The path toward federal cannabis reform remains narrow. Comprehensive legalization still lacks the supermajority needed to overcome procedural hurdles, but momentum continues to build around incremental efforts like banking access and rescheduling.
As the 2025 session continues, pressure from constituents, economic forces, and evolving public opinion may drive further shifts. For now, the Senate reflects a patchwork of positions—some hardened, some shifting—with each senator holding sway over a multi-billion-dollar question: What does the future of legal cannabis in America look like?
Now read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/04/44716802/cannabis-stays-legal-in-germany-following-new-coalition-deal">Cannabis Stays Legal In Germany Following New Coalition Deal</a></li>
</ul>
Photo: Shutterstock

Cannabis

Government

Politics

Who's Blocking Cannabis Reform In The Senate? Marijuana Policy Still Divides Democrats And Republicans

Wall Street staged one of its most powerful rallies in history on Wednesday, as a dramatic shift in U.S. trade policy ignited an aggressive risk-on surge across <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty">every corner of the market.</a>
At the heart of the rally was President Donald Trump's unexpected announcement of a 90-day tariff pause for countries that have not retaliated against the U.S., coupled with a renewed hardline stance on China. 
The twin messaging—conciliatory toward allies, confrontational toward Beijing—was seen by investors as a calculated move to reset trade negotiations and de-escalate uncertainty.
Trump decided to impose universal 10% tariffs on countries that have not retaliated against U.S. duties, announcing a three-month window for fine-tuning negotiations. He also opted to keep duties on China as high as 125%.
The reaction was immediate and overwhelming.
The Nasdaq 100 – as tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) – soared 11% by 2:40 p.m. ET, on track for its strongest one-day gain since October 2008, during the height of the global financial crisis. 
The S&amp;P 500 jumped 8.7%, its best session since March 2020, while the Dow Jones Industrial Average surged 7.3%, also notching a post-COVID record. 
Meanwhile, the Russell 2000, which tracks domestic-focused small caps, rocketed 9.1%, nearing one of its best sessions since the index&#8217;s inception in 1987.
<h3 class="wp-block-heading">Mega-Cap Stocks Skyrocket </h3>
The Magnificent Seven stocks added a combined $1.44 trillion in market capitalization in a single session, in what is shaping up to be one of the largest single-day gains in aggregate market value ever recorded for the U.S. tech titans.
<ul>
<li>NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped 15.88%, adding $373.12 billion in market capitalization.</li>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rallied 11.72%, gaining $258.23 billion.</li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) rose 8.17%, up $215.33 billion.</li>
<li>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) climbed 9.64%, increasing its market value by $174.34 billion</li>
<li>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) advanced 10.05%, adding $152.22 billion.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) surged 7.82%, with a $138.74 billion boost.</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) soared 18.60%, gaining $132.73 billion.</li>
</ul>
The Roundhill Magnificent Seven ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>) soared 11%, its largest one-day jump since the fund&#8217;s inception in 2023.
"This was brilliantly executed by Donald Trump. Textbook, Art of the Deal," hedge fund titan Bill Ackman posted on X, reflecting the enthusiastic reactions from investors.
Economist Mohamed El-Erian noted that while speculation centered on who might have pressured the White House—Congress, CEOs, or courts—it was likely the government bond market that forced the administration's hand: "How close it gets to the line that separates wild price volatility from market malfunctioning," he wrote.
Before Trump's announcement, U.S. Treasuries had come under heavy pressure, with yields climbing amid growing investor skepticism toward American assets.
Market experts saw the move as a potential inflection point. 
"Markets are breathing a loud sigh of relief after President Trump announced a 90-day pause on tariffs and a reduction of certain ones," said Chris Brigati, CIO at SWBC. "The market&#8217;s move upward is violent, and speaks to how badly the market was looking for clarity."
Gina Bolvin, president of Bolvin Wealth Management, called this "the pivotal moment we've been waiting for," adding that the timing, just ahead of earnings season, may give companies a steadier backdrop for forward guidance.
Still, some warned the euphoria may prove temporary. "Uncertainty looms over what happens after the 90-day period," Bolvin said. "This underscores the importance of staying fully invested, particularly in a market as reactive and headline-driven as this one."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44716555/thomas-peterffy-greatest-buying-opportunity-tariffs-roil-markets">Don&#8217;t Panic, Billionaire Thomas Peterffy Says: Tariffs Present &#8216;Greatest&#8217; Buying Opportunity</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Broad U.S. Equity ETFs

ETFs

MAGS

TSLA

Nasdaq 100 Set For Strongest Rally Since 2008 As Magnificent 7 Add $1.5 Trillion In Historic Surge

<a href="https://tinyurl.com/ystz8x2p" title="https://tinyurl.com/ystz8x2p">https://tinyurl.com/ystz8x2p</a>

General

Bloomberg: 'Hackers Breach Berkshire Hathaway's NetJets, Steal Client Data'

Investors with a lot of money to spend have taken a bullish stance on UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UNH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 58 uncommon options trades for UnitedHealth Group.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 18%, bearish.
Out of all of the special options we uncovered, 23 are puts, for a total amount of $1,709,903, and 35 are calls, for a total amount of $6,126,227.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $240.0 to $610.0 for UnitedHealth Group over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in UnitedHealth Group's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to UnitedHealth Group's substantial trades, within a strike price spectrum from $240.0 to $610.0 over the preceding 30 days.
<h3>UnitedHealth Group Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744225368_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$339.0</td>
<td>$332.5</td>
<td>$332.5</td>
<td>$240.00</td>
<td>$1.6M</td>
<td>5.4K</td>
<td align="right">100</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$331.75</td>
<td>$328.5</td>
<td>$331.75</td>
<td>$240.00</td>
<td>$1.6M</td>
<td>5.4K</td>
<td align="right">50</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$328.0</td>
<td>$324.3</td>
<td>$328.0</td>
<td>$240.00</td>
<td>$820.0K</td>
<td>5.4K</td>
<td align="right">100</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$26.0</td>
<td>$24.3</td>
<td>$26.0</td>
<td>$610.00</td>
<td>$455.0K</td>
<td>82</td>
<td align="right">175</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$323.0</td>
<td>$320.75</td>
<td>$323.0</td>
<td>$240.00</td>
<td>$323.0K</td>
<td>5.4K</td>
<td align="right">215</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
<h3>UnitedHealth Group's Current Market Status</h3>
<ul>
<li>Trading volume stands at 8,791,011, with UNH's price up by 4.76%, positioned at $579.42.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>Professional Analyst Ratings for UnitedHealth Group</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $650.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on UnitedHealth Group with a target price of $650. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for UnitedHealth Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Unpacking the Latest Options Trading Trends in UnitedHealth Group

Deep-pocketed investors have adopted a bullish approach towards Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NFLX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 72 extraordinary options activities for Netflix. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 34 are puts, totaling $2,900,610, and 38 are calls, amounting to $2,206,578.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $440.0 to $1140.0 for Netflix over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Netflix's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Netflix's whale activity within a strike price range from $440.0 to $1140.0 in the last 30 days. 
<h3>Netflix Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744225364_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$50.5</td>
<td>$49.6</td>
<td>$49.6</td>
<td>$870.00</td>
<td>$471.2K</td>
<td align="right">554</td>
<td align="right">374</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$15.2</td>
<td>$15.05</td>
<td>$15.05</td>
<td>$500.00</td>
<td>$168.5K</td>
<td align="right">697</td>
<td align="right">115</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$73.85</td>
<td>$69.45</td>
<td>$69.45</td>
<td>$870.00</td>
<td>$166.6K</td>
<td align="right">158</td>
<td align="right">588</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$76.65</td>
<td>$71.4</td>
<td>$73.65</td>
<td>$880.00</td>
<td>$162.0K</td>
<td align="right">376</td>
<td align="right">783</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$98.35</td>
<td>$94.75</td>
<td>$98.35</td>
<td>$905.00</td>
<td>$157.3K</td>
<td align="right">99</td>
<td align="right">35</td>
</tr>
</tbody>
</table>

<h3>About Netflix</h3>
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
Having examined the options trading patterns of Netflix, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Netflix's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,300,061, with NFLX's price up by 6.66%, positioned at $928.4.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>What The Experts Say On Netflix</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $1056.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Netflix, which currently sits at a price target of $1000. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Netflix, targeting a price of $1025. 
&#x2A; An analyst from MoffettNathanson has elevated its stance to Buy, setting a new price target at $1100. 
&#x2A; Reflecting concerns, an analyst from Guggenheim lowers its rating to Buy with a new price target of $1100.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Netflix options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

NFLX

Netflix Unusual Options Activity

Financial giants have made a conspicuous bullish move on Boeing. Our analysis of options history for Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) revealed 40 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 20 were puts, with a value of $1,957,406, and 20 were calls, valued at $1,045,558.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $200.0 for Boeing, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Boeing's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Boeing's whale activity within a strike price range from $120.0 to $200.0 in the last 30 days. 
<h3>Boeing 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744225358_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$33.5</td>
<td>$31.1</td>
<td>$33.5</td>
<td>$155.00</td>
<td>$670.0K</td>
<td>2.5K</td>
<td align="right">200</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$37.2</td>
<td>$36.5</td>
<td>$36.5</td>
<td>$160.00</td>
<td>$456.2K</td>
<td>417</td>
<td align="right">125</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$31.0</td>
<td>$26.05</td>
<td>$28.45</td>
<td>$120.00</td>
<td>$142.2K</td>
<td>168</td>
<td align="right">0</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/25/25</td>
<td>$4.5</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$155.00</td>
<td>$107.1K</td>
<td>798</td>
<td align="right">1</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$12.35</td>
<td>$12.3</td>
<td>$12.3</td>
<td>$145.00</td>
<td>$97.1K</td>
<td>1.4K</td>
<td align="right">81</td>
</tr>
</tbody>
</table>

<h3>About Boeing</h3>
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
After a thorough review of the options trading surrounding Boeing, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Boeing Standing Right Now?</h3>
<ul>
<li>With a volume of 11,258,634, the price of BA is up 12.55% at $156.89. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
<h3>What The Experts Say On Boeing</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $113.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Underweight rating on Boeing, which currently sits at a price target of $113. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Boeing options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Looking At Boeing's Recent Unusual Options Activity

ACGL

ALLY

ARCC

ARES

BXSL

CADE

COLB

DBRG

EWBC

FITB

FULT

FUTU

HBAN

HOMB

HSBC

IBKR

NDAQ

OBDC

SOFI

TROW

UPST

VOYA

Shares of banks and financial services companies are trading higher amid an overall market surge following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

In the last three months, 10 analysts have published ratings on Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $114.9, a high estimate of $127.00, and a low estimate of $106.00. Experiencing a 3.12% decline, the current average is now lower than the previous average price target of $118.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1744225280_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Arch Capital Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Brian Meredith &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $124.00&#x7C;$127.00 &#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $107.00&#x7C;$106.00 &#x7C; 
&#x7C;Brian Meredith &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $127.00&#x7C;$131.00 &#x7C; 
&#x7C;Michael Phillips &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $110.00&#x7C;$115.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $113.00&#x7C;$120.00 &#x7C; 
&#x7C;Scott Heleniak &#x7C;RBC Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $110.00&#x7C;$125.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $106.00&#x7C;$107.00 &#x7C; 
&#x7C;Matthew Carletti &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $125.00&#x7C;$125.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $107.00&#x7C;$109.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $120.00&#x7C;$121.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Arch Capital Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Arch Capital Group compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Arch Capital Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Arch Capital Group's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ACGL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Arch Capital Group analyst ratings.</a>
<h2>Delving into Arch Capital Group's Background</h2>
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
<h3>Key Indicators: Arch Capital Group's Financial Health</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Arch Capital Group's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 19.09%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Arch Capital Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 20.51% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Arch Capital Group's ROE stands out, surpassing industry averages. With an impressive ROE of 4.46%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.28%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.14.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

10 Analysts Have This To Say About Arch Capital Group

Ratings for MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $96.1, a high estimate of $109.00, and a low estimate of $86.00. This upward trend is evident, with the current average reflecting a 1.28% increase from the previous average price target of $94.89.
<img src="https://www.benzinga.com/files/images/story/2025/1744225266_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of MetLife's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $95.00&#x7C;$98.00 &#x7C; 
&#x7C;Brian Meredith &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $98.00&#x7C;$94.00 &#x7C; 
&#x7C;John Barnidge &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $94.00&#x7C;$92.00 &#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $86.00&#x7C;$88.00 &#x7C; 
&#x7C;Nigel Dally &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $109.00&#x7C;$101.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $97.00&#x7C;$92.00 &#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $98.00&#x7C;$100.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $95.00&#x7C;$96.00 &#x7C; 
&#x7C;Jack Matten &#x7C;BMO Capital &#x7C;Announces &#x7C;Market Perform &#x7C; $97.00&#x7C;- &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $92.00&#x7C;$93.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to MetLife. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of MetLife compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for MetLife's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of MetLife's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MET/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MetLife analyst ratings.</a>
<h2>Get to Know MetLife Better</h2>
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
<h3>Financial Milestones: MetLife's Journey</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: MetLife's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -3.43%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: MetLife's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.74%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.25%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): MetLife's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.18%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 0.68, MetLife faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

10 Analysts Have This To Say About MetLife

QCOM

Qualcomm shares are tarding higher. TD Cowne maintained a Buy rating on the stock.

Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Popular, presenting an average target of $112.25, a high estimate of $129.00, and a low estimate of $100.00. Witnessing a positive shift, the current average has risen by 4.18% from the previous average price target of $107.75.
<img src="https://www.benzinga.com/files/images/story/2025/1744225240_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Popular. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Timur Braziler &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $100.00&#x7C;$110.00 &#x7C; 
&#x7C;Timur Braziler &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $110.00&#x7C;$105.00 &#x7C; 
&#x7C;Gerard Cassidy &#x7C;RBC Capital &#x7C;Raises &#x7C;Outperform &#x7C; $110.00&#x7C;$100.00 &#x7C; 
&#x7C;Kelly Motta &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $129.00&#x7C;$116.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Popular. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Popular compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Popular's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Popular's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BPOP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Popular analyst ratings.</a>
<h2>Get to Know Popular Better</h2>
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
<h3>Breaking Down Popular's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Popular's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.97%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Popular's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 24.63%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.12%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Popular's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.25%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.22, Popular adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BPOP

Analyst Expectations For Popular's Future

In the current market session, Kraft Heinz Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) price is at $28.64, after a 3.43% spike. However, over the past month, the stock decreased by 5.48%, and in the past year, by 21.71%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1744225234_0.png" alt="Past Year Chart" />

<h3>Kraft Heinz P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Kraft Heinz has a lower P/E than the aggregate P/E of 22.09 of the Food Products industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744225234_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Kraft Heinz Inc's Price Over Earnings

In the preceding three months, 9 analysts have released ratings for Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.22, a high estimate of $35.00, and a low estimate of $10.00. This upward trend is evident, with the current average reflecting a 10.39% increase from the previous average price target of $21.94.
<img src="https://www.benzinga.com/files/images/story/2025/1744225231_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Bloom Energy by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;---------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Skye Landon &#x7C;Redburn Atlantic &#x7C;Lowers &#x7C;Sell &#x7C; $10.00&#x7C;$14.50 &#x7C; 
&#x7C;Samantha Hoh &#x7C;HSBC &#x7C;Maintains &#x7C;Buy &#x7C; $25.00&#x7C;$25.00 &#x7C; 
&#x7C;Stephen Byrd &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $35.00&#x7C;$28.00 &#x7C; 
&#x7C;Maheep Mandloi &#x7C;Mizuho &#x7C;Announces &#x7C;Neutral &#x7C; $28.00&#x7C;- &#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $31.00&#x7C;$33.00 &#x7C; 
&#x7C;Julien Dumoulin-Smith&#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $18.00&#x7C;$20.00 &#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $33.00&#x7C;$30.00 &#x7C; 
&#x7C;Mark Strouse &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $16.00&#x7C;$14.00 &#x7C; 
&#x7C;Jordan Levy &#x7C;Truist Securities &#x7C;Raises &#x7C;Hold &#x7C; $22.00&#x7C;$11.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bloom Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bloom Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Bloom Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Bloom Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Bloom Energy analyst ratings.</a>
<h2>Get to Know Bloom Energy Better</h2>
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
<h3>Bloom Energy: A Financial Overview</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Bloom Energy displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 60.37%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Bloom Energy's net margin excels beyond industry benchmarks, reaching 18.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 21.1%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.98%, the company showcases effective utilization of assets.
Debt Management: Bloom Energy's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.72, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Bloom Energy's Future

Mattel's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NYSE">MAT</a>) short percent of float has fallen 6.53% since its last report. The company recently reported that it has 15.08 million shares sold short, which is 7.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Mattel Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744225230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Mattel has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Mattel's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Mattel's peer group average for short interest as a percentage of float is 8.63%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What's Driving the Market Sentiment Around Mattel?

Press Releases

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Enveric Biosciences Announces Closing of $5 Million Public Offering

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum

Enveric Biosciences CEO Issues Letter to Shareholders

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Enveric Biosciences Participating in BIO-Europe Spring®

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

ONVO

PNPNF

PRSO

TRNR

TSXV:PNPN

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Akanda

Artelo Biosciences

CNS Pharma

China Pharma Holding

Evoke Pharma

Eyenovia

Hepion Pharmaceuticals, Inc. - Common Stock

Hepion Pharmaceuticals

Jaguar Health

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

cbdMD

HC Wainwright & Co.

Alliance Global Partners

Doctor,Hand,Holding,A,Holographic,Of,Human,Brain,In,Healthcare

Biotech

Enveric Biosciences Presents Compelling Preclinical Data On Lead Compound EB-003 At 7th Neuropsychiatric Drug Summit

Comments

Enveric Biosciences

Noticias

Últimas noticias sobre Enveric Biosciences (NASDAQ:ENVB) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL